Eu Yan Sang offeror faces stumbling block in compulsory acquisition
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
ALTHOUGH the public float in Eu Yan Sang International (EYSI) has fallen below the required 10 per cent for it to stay listed, the consortium making the bid to take the traditional Chinese medicine (TCM) group private is still not entitled to proceed with compulsory acquisition of shares that it does not already own.
Standing in the way are two substantial shareholders - Hillhouse Capital Management Ltd and TFW Fund - which have a combined stake of 10.6 per cent. Substantial stakes are not counted as part of public float.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium